Prostate Cancer Foundation
54
17
24
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.3%
5 terminated/withdrawn out of 54 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
55%
11 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (54)
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Role: collaborator
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Role: collaborator
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Role: collaborator
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
Role: collaborator
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
Role: collaborator
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
Role: collaborator
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
Role: collaborator
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer
Role: collaborator
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Role: collaborator
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer
Role: collaborator
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Role: collaborator
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Role: collaborator
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Role: collaborator
Mechanisms of Resistance to PSMA Radioligand Therapy
Role: collaborator
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
Role: collaborator
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Role: collaborator
RElugolix VErsus LeUprolide Cardiac Trial
Role: collaborator
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Role: collaborator
Ablative Therapy in the Management of Prostate Cancer
Role: collaborator
TmPSMA-02 in mCRPC
Role: collaborator